Search details
1.
Pathological Outcomes of Patients With Advanced Renal Cell Carcinoma Who Receive Nephrectomy Following Immunotherapy.
Oncologist
; 2023 Jun 27.
Article
in English
| MEDLINE | ID: mdl-37368355
2.
Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study.
Lancet Oncol
; 20(4): 581-590, 2019 04.
Article
in English
| MEDLINE | ID: mdl-30827746
3.
A targeted next-generation sequencing assay detects a high frequency of therapeutically targetable alterations in primary and metastatic breast cancers: implications for clinical practice.
Oncologist
; 19(5): 453-8, 2014 May.
Article
in English
| MEDLINE | ID: mdl-24710307
4.
End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy.
JCO Oncol Pract
; 19(2): e213-e227, 2023 02.
Article
in English
| MEDLINE | ID: mdl-36413741
5.
Outcomes of Consolidative Nephrectomy following Primary Immunotherapy in Advanced Renal Cell Carcinoma: A Multicenter Analysis.
Clin Genitourin Cancer
; 21(6): 694-702, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37558529
6.
Bridging New Technology Into Clinical Practice With Mobile Apps, Electronic Patient-Reported Outcomes, and Wearables.
Am Soc Clin Oncol Educ Book
; 42: 1-6, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-35522912
7.
Referral and adjuvant treatment patterns after nephrectomy in high-risk locoregional renal cell carcinoma.
Cancer Med
; 10(24): 8891-8898, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34751002
8.
Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma.
JAMA Oncol
; 7(12): 1815-1823, 2021 Dec 01.
Article
in English
| MEDLINE | ID: mdl-34673916
9.
Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study.
J Immunother Cancer
; 8(1)2020 03.
Article
in English
| MEDLINE | ID: mdl-32217762
10.
Reply to L. Marandino et al.
J Clin Oncol
; 40(19): 2175-2176, 2022 07 01.
Article
in English
| MEDLINE | ID: mdl-35446593
11.
Elevating the Patient Voice in Metastatic Hormone-Sensitive Prostate Cancer Clinical Trials.
J Clin Oncol
; 40(8): 807-810, 2022 03 10.
Article
in English
| MEDLINE | ID: mdl-34990219
12.
Triplet Therapy: Entering the Metaverse of Metastatic Hormone-sensitive Prostate Cancer Treatment.
Eur Urol
; 82(6): 599-601, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36114081
13.
Impacts of Early Guideline-Directed 21-Gene Recurrence Score Testing on Adjuvant Therapy Decision Making.
J Oncol Pract
; 13(12): e1012-e1020, 2017 12.
Article
in English
| MEDLINE | ID: mdl-29048991
14.
T-DM1 Activity in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancers That Received Prior Therapy With Trastuzumab and Pertuzumab.
J Clin Oncol
; 34(29): 3511-3517, 2016 10 10.
Article
in English
| MEDLINE | ID: mdl-27298406
Results
1 -
14
de 14
1
Next >
>>